Safety of the oxaliplatin readministration by the desensitization for metastatic colorectal cancer patients having oxaliplatin allergy
Not Applicable
- Conditions
- Colorectal carcinoma
- Registration Number
- JPRN-UMIN000010128
- Lead Sponsor
- Aichi Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1 History of desensitization for oxaliplatin 2 history of oxaliplatin hypersensitivity Grade4 3 Uncontrollable diabetes mellitus 4 Regularly using steroid 5 Uncontrollable heart disease 6 Other severe complications such as renal failure liver failure and intestinal pneumonitis 7 Symptomatic CNS metastasis 8 Active bacterial or fungous infection 9 Massive pleural effusion or massive ascites 10 Active bleeding 11 Active double cancer 12 Patient evaluated to be inadequate by a attending doctor 13 Other conditions not suitable for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method